Con­tro­ver­sial pa­tient deaths in CAR-T study spur a class ac­tion suit against Juno

Juno con­tin­ues to feel the fall­out from its painful, and very brief, tri­al hold for its lead CAR-T JCAR015. In a new­ly filed class ac­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.